Call Girl In Indore 📞9235973566📞Just Call Inaaya📲 Call Girls Service In Indor...
Measles and rubella monthly update for the WHO European Region
1. Measles and rubella monthly update for the
WHO European Region
Data as of 4 March 2019
Vaccine-preventable Diseases and Immunization programme
Division of Health Emergencies and Communicable Diseases
5. Data source: Monthly aggregated and case-based data reported by Member States to WHO/Europe directly or via ECDC/TESSy data as of 4 March 2019
1509
1727
2050
2092
2632
2800
3176
3377
4176
63948
0 10000 20000 30000 40000 50000 60000 70000
Kyrgyzstan
Greece
Russian Federation
Kazakhstan
Italy
France
Georgia
Israel
Serbia
Ukraine
Number of cases
Ten countries with the highest numbers of measles cases in the WHO European
Region, February 2018–January 2019
Out of 95 547 measles cases reported for February 2018 to
January 2019, 87 487 (92%) cases were reported by these
10 countries.
5
6. Data source: Monthly aggregated and case-based data reported by Member States to WHO/Europe directly or via ECDC/TESSy data as of 4 March 2019
Measles cases by month in the WHO European Region, 2017–January 2019
6
0
2000
4000
6000
8000
10000
12000
14000
16000
18000
20000
Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
Jan
2017
(n=25869)
2018
(n=83103)
2019
Numberofcases
Month
Lab confirmed Epi linked Clinically compatible
(n=18112)
Criteria for date of case inclusion may differ in accordance with Member States’ surveillance systems.
11. Data source: Monthly aggregated and case-based data reported by Member States to WHO/Europe directly or via ECDC/TESSy data as of 4 March 2019
1100
1466
2193
2203
2256
2686
2913
3122
5076
53218
0 10000 20000 30000 40000 50000 60000
Kyrgyzstan
Albania
Greece
Georgia
Russian Federation
Italy
France
Israel
Serbia
Ukraine
Number of cases
Ten countries with the highest numbers of measles cases in the WHO European
Region, 2018
Out of 83 103 measles cases reported for 2018,
76 233 (92%) cases were reported by these 10 countries.
11
12. Data source: Monthly aggregated and case-based data reported by Member States to WHO/Europe directly or via ECDC/TESSy data as of 4 March 2019
Measles cases by month in the WHO European Region, 2016–2018
12
0
2000
4000
6000
8000
10000
12000
14000
Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
2016
(n=5273)
2017
(n=25869)
2018
(n=83103)
Numberofcases
Month
Lab confirmed Epi linked Clinically compatible
Criteria for date of case inclusion may differ in accordance with Member States’ surveillance systems.
13. Data source: Monthly aggregated and case-based data reported by Member States to WHO/Europe directly or via ECDC/TESSy data as of 4 March 2019
Measles cases and incidence by age group and vaccination status in the WHO
European Region, 2018*
13
Population source: United Nations, Department of Economic and Social Affairs, Population Division. World Population Prospects: The 2017 Revision.
*Age was unknown for 7 cases.
607
321
235
182 165
114
29
0
100
200
300
400
500
600
700
0
2000
4000
6000
8000
10000
12000
14000
16000
18000
<1
(n=6553)
1-4
(n=14488)
5-9
(n=13323)
10-14
(n=9728)
15-19
(n=8439)
20-29
(n=13452)
30+
(n=17113)
Incidencepermillionpopulation
Numberofcases
Age group (years)
0 dose 1 dose 2+ doses Unknown Incidence
14. 14
7884
30604
33254
26788
32857
18869
28413
5273
25863
83103
94 93 94 95 95 94 94 93
95
73
80
83 83
89 89 89 88
90
0
20
40
60
80
100
2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
0
10000
20000
30000
40000
50000
60000
70000
80000
90000
%Coverage
Year
Numberofcases
Measles cases MCV1 coverage MCV2 coverage
Measles cases, MCV1 and MCV2 coverage by year in the WHO European Region,
2009–2018
Data source: 1) Measles cases – monthly aggregated and case-based data reported by Member States to WHO/Europe or via ECDC/TESSy as of 4 March 2019.
2) MCV1 and MCV2 coverage - WHO/UNICEF Estimates of National Immunization Coverage (WUENIC) as of 8 Nov 2018.
MCV1: first dose of measles-containing vaccine
MCV2: second dose of measles-containing vaccine
16. Data source: Monthly aggregated and case-based data reported by Member States to WHO/Europe directly or via ECDC/TESSy data as of 4 March 2019
19
22
50
228
461
0 50 100 150 200 250 300 350 400 450 500
Spain
Italy
Germany
Ukraine
Poland
Number of cases
Five countries with the highest numbers of rubella cases in the WHO European
Region, February 2018–January 2019
16
Out of 846 rubella cases reported for February 2018
to January 2019, 780 (92%) cases were reported by
these 5 countries.
17. Data source: Monthly aggregated and case-based data reported by Member States to WHO/Europe directly or via ECDC/TESSy data as of 4 March 2019
Rubella cases by month in the WHO European Region, 2017–January 2019
17
0
20
40
60
80
100
120
Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
Jan
2017
(n=703)
2018
(n=850)
2019
Numberofcases
Month
Lab confirmed Epi linked Clinically compatible
(n=78)
Criteria for date of case inclusion may differ in accordance with Member States’ surveillance systems.
19. Data source: Monthly aggregated and case-based data reported by Member States to WHO/Europe directly or via ECDC/TESSy data as of 4 March 2019
16
21
57
235
450
0 50 100 150 200 250 300 350 400 450 500
Turkey
Italy
Germany
Ukraine
Poland
Number of cases
Five countries with the highest numbers of rubella cases in the WHO European
Region, 2018
19
Out of 850 rubella cases reported for 2018, 779 (92%)
cases were reported by these 5 countries.
20. Data source: Monthly aggregated and case-based data reported by Member States to WHO/Europe directly or via ECDC/TESSy data as of 4 March 2019
Rubella cases by month in the WHO European Region, 2016–2018
20
Criteria for date of case inclusion may differ in accordance with Member States’ surveillance systems.
0
20
40
60
80
100
120
140
160
180
200
Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
2016
(n=1322)
2017
(n=703)
2018
(n=850)
Numberofcases
Month
Lab confirmed Epi linked Clinically compatible